Search results
ZYMUTEST TAFI (Activatable)
Assay proposed for the measurement of TAFI in research applications.
Thrombin, Human, inactivated
Thrombin (α-Form), Human
Factor X Deficient Plasma
Measurement of factor X (FX or stuart factor) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human FX deficient plasma is required
Factor XIII Deficient Plasma
For any in vitro protocol or research study where a source of human FXIII deficient plasma is required.
Factor XII Deficient Plasma
Measurement of factor XII (FXII or factor hageman) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent).For any in vitro protocol or research study where a source of human FXII deficient plasma is required.
BIOPHEN DTI (Direct Thrombin Inhibitors)
Assay proposed for the measurement of anti-IIa activity in research applications.
BIOPHEN Heparin anti-IIa (Kinetics)
Assay proposed for the measurement of heparin in research applications.
BIOPHEN Heparin anti-IIa (2-stages) -> SEE NEW REF. 220005
Assay proposed for the measurement of heparin anti-thrombin activity in research applications acc. to Pharmacopoeia.
Factor VII Deficient Plasma
Measurement of factor VII (FVII / proaccelerin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human FVII deficient plasma is required